Literature DB >> 3314913

Sex steroid receptor distribution in the human larynx and laryngeal carcinoma.

B J Ferguson1, W R Hudson, K S McCarty.   

Abstract

Previous reports of estrogen receptor (ER) and progesterone receptor (PgR) in the human larynx and laryngeal carcinoma have relied on ligand-binding techniques using cytosol from tissue homogenates. These methods obscure the contribution of different tissue components to total receptor content. Recently developed, highly specific monoclonal antibodies to human ER and PgR were able to discern the presence of ER and PgR at the cellular level in 12 specimens of normal laryngeal tissue and eight laryngeal squamous cell carcinomas. Localization of ER and PgR was observed in the nuclei of vocalis muscle. No evidence of ER or PgR was found in epithelial components of the normal larynges or in laryngeal carcinomas. These results extend previous findings in lower primates and rodents to the human larynx and clarify previously reported receptor analyses of laryngeal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314913     DOI: 10.1001/archotol.1987.01860120057008

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  14 in total

1.  [The effect of hormonal agents on the development of chronic laryngitis and tumor disease. Report of two cases].

Authors:  D Kleemann; B Stengel
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

2.  Dietary fiber and grain consumption in relation to head and neck cancer in the NIH-AARP Diet and Health Study.

Authors:  Tram Kim Lam; Amanda J Cross; Neal Freedman; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Christian Abnet
Journal:  Cancer Causes Control       Date:  2011-07-23       Impact factor: 2.506

3.  Androgen receptors and gender-specific distribution of alkaline phosphatase in human thyroid cartilage.

Authors:  Horst Claassen; Heiner Mönig; Saadettin Sel; Jochen A Werner; Friedrich Paulsen
Journal:  Histochem Cell Biol       Date:  2006-04-01       Impact factor: 4.304

4.  Quality prevails over identity in the sexually selected vocalisations of an ageing mammal.

Authors:  Elodie Briefer; Elisabetta Vannoni; Alan G McElligott
Journal:  BMC Biol       Date:  2010-04-09       Impact factor: 7.431

Review 5.  The nature of the head and neck cancer.

Authors:  A G Maran; J A Wilson; M N Gaze
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

6.  Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma.

Authors:  Ann Marie Egloff; Mary E Rothstein; Raja Seethala; Jill M Siegfried; Jennifer Rubin Grandis; Laura P Stabile
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

7.  Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

Authors:  Serdar Karahatay; Kesha Thomas; Serap Koybasi; Can E Senkal; Saeed Elojeimy; Xiang Liu; Jacek Bielawski; Terry A Day; M Boyd Gillespie; Debajyoti Sinha; James S Norris; Yusuf A Hannun; Besim Ogretmen
Journal:  Cancer Lett       Date:  2007-07-09       Impact factor: 8.679

8.  Detection of hormone receptors in the human vocal fold.

Authors:  Ch Voelter; N Kleinsasser; P Joa; I Nowack; R Martínez; R Hagen; H U Voelker
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10       Impact factor: 2.503

9.  Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations.

Authors:  Chiara Bianchini; Antonio Pastore; Stefano Pelucchi; Elena Torreggiani; Elisabetta Lambertini; Elena Marchesi; Eros Magri; Claudia Frasson; Patrizia Querzoli; Roberta Piva
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

10.  The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma.

Authors:  Kresimir Grsic; Iva Ledinsky Opacic; Sanda Sitic; Marija Milkovic Perisa; Petar Suton; Bozena Sarcevic
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.